Scabies
Scabies is a contagious skin infestation caused by a tiny mite, Sarcoptes scabiei. The mites burrow into the outer skin and cause an allergic reaction, usually with intense itching and a rash. It spreads mainly through close skin-to-skin contact, including within households. People can pass it on before symptoms appear. Clothing and bedding are less important in ordinary scabies but can spread the highly contagious crusted form. Scabies occurs worldwide and is particularly common in crowded, resource-poor tropical settings. It is more than an irritation: scratching and skin damage can lead to bacterial infections, sometimes with serious bloodstream or kidney complications. Crusted scabies can be life-threatening, especially in people with weakened immune systems. Treatment uses medicines applied to the skin or taken by mouth. Treating household members together and cleaning relevant clothing and bedding help prevent reinfestation. The sources retrieved here do not establish a case-fatality rate, a reproduction number, or vaccine availability. The site's lack of archived WHO outbreak notices does not mean scabies is rare.
Key facts
| Transmission | Mainly close person-to-person skin contact; transmission can occur before symptoms. Clothing and bedding are more important in crusted scabies than in ordinary scabies. |
|---|---|
| Incubation | WHO reports that symptoms usually begin 4–6 weeks after infestation. |
| Case fatality | Unknown; the retrieved sources provide no rate with or without treatment. Serious bacterial complications and crusted scabies can be life-threatening. |
| Reproduction number | Unknown; no R0 or secondary attack rate was established in the retrieved sources. |
| Vaccine | Unknown from the retrieved sources; vaccine availability was not established. |
| Treatment | Whole-body topical treatment, including 5% permethrin cream, or oral medication in more severe cases. Household members should be treated together. |
| Reservoir | Humans sustain person-to-person transmission of human scabies. Sarcoptes scabiei also infests other mammals, but the retrieved sources do not establish their role in maintaining human scabies. |
| Endemic regions | Worldwide, with a particularly high burden in resource-poor tropical settings. |
Transmission
Scabies spreads mainly through close skin-to-skin contact with someone who has the infestation. Living in the same household is an important setting for transmission. A person may pass on mites before developing itching or a rash, because symptoms are delayed. The risk increases with the number of mites on the skin. Crusted scabies is especially contagious. WHO says transmission through clothing or bed linen is unlikely in ordinary scabies, but these items can matter in crusted scabies. Prevention therefore combines treatment of people with attention to shared surroundings. Household members should be treated together, and clothing and bedding used by the affected person should be cleaned according to health advice.
- Scabies WHO
Symptoms and severity
The usual symptoms are intense itching, often worse at night, and small bumps or thin burrow-like lines in the skin. Common sites include the spaces between fingers, wrists, limbs and waist. Infants and small children may have a wider rash, including the palms, soles and scalp. WHO reports that symptoms usually start 4–6 weeks after infestation. Scratching and skin damage can allow bacteria to enter, causing sores, abscesses or bloodstream infection. Associated bacterial infections can also contribute to kidney problems. People with weakened immune systems may develop crusted scabies, with thick, scaly skin and very large numbers of mites. This form may cause little itching despite being highly contagious and potentially life-threatening. No case-fatality rate was established by the retrieved sources.
- Scabies WHO
- Scabies: more than just an irritation. Europe PMC · 1 Jul 2004
Treatment and vaccines
Scabies can be treated with medicines applied to the skin or with oral medication in more severe cases. WHO lists whole-body topical treatments, including 5% permethrin cream. Treatment needs to address contacts as well as the person with symptoms: WHO recommends treating all household members to prevent continued spread. Relevant bedding and clothing should be washed and dried using the methods WHO describes; items that cannot be washed can be sealed in a plastic bag for a week. Itching can worsen for 1–2 weeks after treatment starts, so itching alone does not prove treatment has failed. A literature review identifies delayed diagnosis and incorrect treatment use as barriers to control. The retrieved sources did not establish vaccine availability.
Where it occurs
Scabies occurs in every country. WHO describes the greatest burden in resource-poor tropical settings, particularly among children and older people. Poverty, crowding and difficulties accessing diagnosis and treatment can make sustained control harder. In high-income countries, individual cases still occur, and outbreaks in health institutions and vulnerable communities can place substantial demands on services. The overview source also identifies care homes, schools, refugee camps, prisons and hospitals as settings of concern. A 2007 review described a high burden in some remote Aboriginal communities in northern Australia. These examples should not be read as an exclusive geographic list: scabies is a worldwide condition, and local risk depends strongly on contact patterns and access to effective care.
- Scabies WHO
- Scabies Wikipedia
- Problems in diagnosing scabies, a global disease in human and animal populations. Europe PMC · 1 Apr 2007
Recent history
As of 2026-11-15, this site's supplied archive count is zero scabies events, and the archive lookup returned no events for the scabies key. A search of WHO Disease Outbreak News titles also returned no titles containing “scabies.” These are limits of the archive and title search, not evidence that outbreaks have not occurred. The site lists “Scabies in Czechia” as a monitoring record, but no supporting event report was retrieved here, so this page gives no current Czech case count or trend. A 2019 public-health review reports that WHO added scabies to its neglected tropical disease list in 2017. That review highlights population-level control, including mass treatment campaigns, as an important research and public-health priority.
- The public health control of scabies: priorities for research and action. Europe PMC · 6 Jun 2019
What to watch
Important warning signals include growing clusters in households or institutions, delayed recognition of crusted scabies, and increasing bacterial skin infections or serious complications. Human-to-human transmission is already the normal route, so its mere presence is not a new warning sign. Because scabies occurs worldwide, sustained local increases or spread into previously unaffected institutions are more informative than a report from a new country alone. Repeated cases after coordinated treatment deserve investigation, including whether contacts were treated and medicines were used correctly. Poor response should not automatically be labelled drug resistance; the retrieved sources do not establish its current frequency. Difficulty obtaining treatment could undermine control. Vaccine supply cannot be assessed here because the retrieved sources did not establish vaccine availability.
- Scabies WHO
- Scabies. Europe PMC · 1 May 2006
- The public health control of scabies: priorities for research and action. Europe PMC · 6 Jun 2019
Related outbreaks
- Scabies in Czechia moderate